Related Articles
Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer
Comparison of intravesical bacillus Calmette‑Guerin and mitomycin C administration for non‑muscle invasive bladder cancer: A meta‑analysis and systematic review
Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment
Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer